Prostate cancer Board decisions

The Veteran's claims for service connection for prostate cancer and non-Hodgkin's lymphoma have been reopened due to new evidence submitted after the previous denial. The Board has decided that these issues should be remanded for further review.

The Board has determined that new evidence submitted by the Veteran since the last denial of service connection for intestinal disability, prostate cancer, kidney disease, COPD, heart disease, diabetes mellitus, anxiety disorder, headache disability, and left shoulder disability warrants a remand to obtain additional medical opinions regarding these issues.,The Veteran's claims for service connection for intestinal disability, prostate cancer, kidney disease, COPD, heart disease, diabetes mellitus, anxiety disorder, headache disability, and left shoulder disability are being remanded due to the submission of new evidence that is relevant to the issues on appeal.

The Veteran's claim for an earlier effective date for a 100 percent disability rating for recurrence of prostate cancer is denied as the evidence does not show a recurrence or metastasis of his prostate cancer prior to October 19, 2020.

The Veteran's prostate cancer residuals are rated at a 60 percent rating, effective from the date of service connection (June 5, 2003). A total disability rating based on individual unemployability is granted prior to May 19, 2021.

The Board has determined that the severance of service connection for prostate cancer and erectile dysfunction was improper, and thus restored service connection for these conditions.

The Veteran's service-connected obstructive sleep apnea is denied as there is no evidence of its occurrence during or post-service.,The Veteran's bilateral sensorineural hearing loss claim is denied due to his failure to report for scheduled VA examinations, and the lack of evidence showing current symptoms or impairment.,The Veteran's prostate cancer with erectile dysfunction residuals are rated at 100% as in remission. The Veteran's TDIU claim is denied as he has not provided sufficient evidence that he is unable to secure or follow a substantially gainful occupation due to his service-connected disabilities.,There was no indication of exposure basis for any condition.

The Veteran's TDIU claim is remanded due to pending service connection claims for Diabetes Mellitus type II, Prostate Cancer, and Stroke with residuals. The outcome of these claims will impact the determination of his TDIU.

The Board has remanded the claims of service connection for diabetes mellitus, type II, hypertension, thyroid condition, and prostate cancer due to exposure to hazardous or toxic chemicals at Aberdeen Proving Ground.

The Board has granted an effective date of August 17, 2018 for a permanent and total rating status for prostate cancer. The Veteran's intent to pursue this claim was received on that date.

The Board has decided to remand the case due to insufficient development regarding exposure to ionizing radiation and the need for a VA examination to determine the nature and etiology of the Veteran's prostate cancer.

The Veteran's initial rating for prostate cancer from January 1, 2019 was denied as the evidence did not show active prostate cancer or continued treatment. The issue of TDIU was dismissed as moot due to the Veteran already receiving SMC based on his total disability ratings.

The Veteran's prostate cancer is presumed to have been incurred as a result of herbicide agent exposure during service at Nakhon Phanom Royal Thai Air Force Base in Thailand.

The Board denied DIC benefits and the claim for service connection for the cause of the Veteran's death because there was no established service-connected disability at the time of his death, and the evidence did not support a finding that any in-service exposure caused or contributed to his prostate cancer.

The Board has remanded several service connection claims, including for sleep apnea, an acquired psychiatric disorder (including memory loss and MDD), bilateral hearing loss, tinnitus, prostate cancer, erectile dysfunction, degenerative arthritis of the spine, right leg arthritis, and left leg arthritis. The Veteran's STRs do not contain any complaints or treatments related to these conditions.

The Board has dismissed the appeals for service connection for diabetes mellitus type II and prostate cancer as they were erroneously docketed twice, and the claims have been granted in a previous decision.

The Board has granted service connection for prostate cancer and hypertension as due to exposure to herbicide agents. The claim of erectile dysfunction as secondary to prostate cancer is remanded.

The Veteran withdrew his appeal for service connection for prostate cancer before the Board could make a decision.

The Veteran's prostate cancer and erectile dysfunction are granted as service connected due to herbicide exposure during his time in Thailand. SMC is also granted for loss of use of a creative organ.

The Veteran's claim for a higher evaluation for his service-connected prostate cancer residuals is being remanded due to the need for an adequate VA examination.

The Veteran's lung cancer, prostate cancer, and hypertension are granted as related to presumed exposure to Agent Orange during service in Vietnam.